Allspring Global Investments Holdings LLC Sells 72,498 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Allspring Global Investments Holdings LLC cut its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 54.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,543 shares of the medical instruments supplier’s stock after selling 72,498 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.24% of ICU Medical worth $9,407,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. State Street Corp lifted its position in ICU Medical by 9.3% in the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock valued at $165,384,000 after acquiring an additional 77,506 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after buying an additional 48,106 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of ICU Medical by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock valued at $54,868,000 after buying an additional 27,927 shares during the period. WCM Investment Management LLC lifted its holdings in shares of ICU Medical by 1.3% during the 3rd quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier’s stock valued at $45,272,000 after buying an additional 3,407 shares during the period. Finally, Victory Capital Management Inc. lifted its holdings in shares of ICU Medical by 0.5% during the 3rd quarter. Victory Capital Management Inc. now owns 142,535 shares of the medical instruments supplier’s stock valued at $25,973,000 after buying an additional 687 shares during the period. 96.10% of the stock is owned by institutional investors.

ICU Medical Trading Up 2.0 %

Shares of ICUI stock opened at $163.44 on Wednesday. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $4.00 billion, a price-to-earnings ratio of -35.76 and a beta of 0.63. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26. The stock’s 50-day moving average price is $160.91 and its 200-day moving average price is $165.38.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. KeyCorp upped their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a research note on Wednesday, December 11th. Finally, Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $199.67.

Insider Transactions at ICU Medical

In other news, COO Christian B. Voigtlander sold 1,430 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director David C. Greenberg sold 972 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total value of $153,682.92. Following the completion of the sale, the director now owns 5,037 shares of the company’s stock, valued at $796,400.07. The trade was a 16.18 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 17,737 shares of company stock valued at $2,879,752 in the last ninety days. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.